Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleACTR-18. PHASE II TRIAL OF TEMOZOLOMIDE AND TRC 102, BASE EXCISION REPAIR INHIBITOR, IN BEVACIZUMAB NAÏVE GLIOBLASTOMA AT FIRST RECURRENCE.AuthorsAhluwalia, Manmeet; Drappatz, Jan; Ye, Xiaobu; Walbert, Tobias; Holdhoff, Matthias; Lesser, Glenn; Cloughesy, Tim; Peereboom, David; Nabors, L Burt; Wen, PatrickPublicationNeuro-Oncology, 2018, Vol 20, pvi15ISSN1522-8517Publication typeArticleDOI10.1093/neuonc/noy148.052